Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Skyclarys
Pharma
Biogen places chips behind 4 new drugs as MS competition mounts
As multiple sclerosis generic competition heats up, Biogen is putting its chips behind four new drugs: Leqembi, Skyclarys, Qalsody and Zurzuvae.
Fraiser Kansteiner
Feb 12, 2025 11:35am
Study says top launches were for drugs for untreated diseases
Nov 6, 2024 9:55am
Biogen raises profit guidance as Leqembi's launch trudges on
Oct 30, 2024 12:30pm
Biogen's fortunes are trending upward thanks to its new launches
Apr 24, 2024 11:24am
Biogen CEO plots turnaround after 'weak' 2023 performance
Feb 13, 2024 11:28am
Biogen and Reata build their blockbuster case for Skyclarys
Feb 12, 2024 5:05pm
